Literature DB >> 7734215

Genetic counselling in the cancer family clinic.

V Murday1.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 7734215     DOI： 10.1016/0959-8049(94)00395-l

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  7 in total

1.  Ascertainment of familial ovarian cancer in the Aberdeen Genetic Clinic.

Authors:  H Gregory; A Schofield; D de Silva; J Semper; B Milner; L Allan; N Haites
Journal:  J Med Genet       Date:  1996-03       Impact factor: 6.318

2.  Determinants of preferences for genetic counselling in Jewish women.

Authors:  Carmel Apicella; Stuart J Peacock; Lesley Andrews; Katherine Tucker; Agnes Bankier; Mary B Daly; John L Hopper
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

3.  Clinical outcome of hereditary breast cancer in the lithuanian population.

Authors:  Pavel Elsakov; Juozas Kurtinaitis; Valerij Ostapenko
Journal:  Hered Cancer Clin Pract       Date:  2005-04-15       Impact factor: 2.857

4.  Probability estimation models for prediction of BRCA1 and BRCA2 mutation carriers: COS compares favourably with other models.

Authors:  Hassan Roudgari; Zosia H Miedzybrodzka; Neva E Haites
Journal:  Fam Cancer       Date:  2007-12-21       Impact factor: 2.375

5.  Breast cancer risk perception: what do we know and understand?

Authors:  P Hopwood
Journal:  Breast Cancer Res       Date:  2000-08-18       Impact factor: 6.466

6.  A descriptive study of UK cancer genetics services: an emerging clinical response to the new genetics.

Authors:  D Wonderling; P Hopwood; A Cull; F Douglas; M Watson; J Burn; K McPherson
Journal:  Br J Cancer       Date:  2001-07-20       Impact factor: 7.640

7.  A randomised comparison of UK genetic risk counselling services for familial cancer: psychosocial outcomes.

Authors:  P Hopwood; D Wonderling; M Watson; A Cull; F Douglas; T Cole; D Eccles; J Gray; V Murday; M Steel; J Burn; K McPherson
Journal:  Br J Cancer       Date:  2004-08-31       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.